The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Acute Care Utilization and Rehospitalizations for Sickle Cell Disease
Open accessAbstract
CONTEXT: Published rates of health care utilization and rehospitalization by people with sickle cell disease have had limited generalizability and are not population based. OBJECTIVE: To provide benchmark data for rates of acute care utilization and rehospitalizations for patients with sickle cell disease. DESIGN: Retrospective cohort of sickle cell disease-related emergency department (ED) visits and hospitalizations from select states in the 2005 and 2006 Healthcare Cost and Utilization Project (HCUP) State Inpatient Databases and State Emergency Department Databases. SETTING: Eight geographically dispersed states (Arizona, California, Florida, Massachusetts, Missouri, New York, South Carolina, and Tennessee) that provide encrypted identifiers and have sufficient numbers of patients with sickle cell disease; together these states have 33% of the US population with sickle cell disease. PATIENTS: A total of 21,112 patients with sickle cell-related treat-and-release ED visits or inpatient hospitalizations. MAIN OUTCOME MEASURES: Rates of acute care utilization and rehospitalizations. Population-based utilization rates were also calculated. RESULTS: The 21,112 people with sickle cell disease had 109,344 encounters, a mean of 2.59 (95% confidence interval [CI], 2.53-2.65) encounters per patient per year, 1.52 (95% CI, 1.48-1.55) encounters for hospitalizations and 1.08 (95% CI, 1.04-1.11) for treat-and-release ED visits. Utilization was highest for 18- to 30-year-olds, 3.61 (95% CI, 3.47-3.75) encounters per patient per year, and those with public insurance, 3.22 (95% CI, 3.13-3.31) encounters per patient per year. Publicly insured 18- to 30-year-olds had 4.80 (95% CI, 4.58-5.02) encounters per patient per year. Approximately 29% of the population had no encounters while 16.9% had 3 or more encounters per year. The 30-day and 14-day rehospitalization rates were 33.4% (95% CI, 33.0%-33.8%) and 22.1% (95% CI, 21.8%-22.4%), respectively. The rehospitalization rate was highest for 18- to 30-year-olds, with 41.1% (95% CI, 40.5%-41.7%) rehospitalized within 30 days and 28.4% (95% CI, 27.8%-29.0%) within 14 days. Rehospitalizations were also highest for publicly insured patients. CONCLUSION: Among patients with sickle cell disease, acute care encounters and rehospitalizations were frequent, particularly for 18- to 30-year-olds.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rehospitalizations among Patients in the Medicare Fee-for-Service Program
Jencks, S. F., Williams, M. V., & Coleman, E. A. (2009) · New England Journal of Medicine · doi:10.1056/nejmsa0803563 · Cited by 5,164
Pain in Sickle Cell Disease: Rates and Risk Factors
Platt, O. S., Thorington, B. D., Brambilla, D. J., Milner, P. F., Rosse, W. F., Vichinsky, E., & Kinney, T. R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199107043250103 · Cited by 1,546
Castro, O., Brambilla, D., Thorington, B., Reindorf, C., Scott, R., Gillette, P., Vera, J., & Levy, P. (1994) · Blood · doi:10.1182/blood.v84.2.643.643 · Cited by 808
Sickle Hemoglobin (Hb S) Allele and Sickle Cell Disease: A HuGE Review
Ashley-Koch, A., Yang, Q., & Olney, R. S. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010288 · Cited by 528
The number of people with sickle‐cell disease in the United States: national and state estimates
Brousseau, D. C., A Panepinto, J., Nimmer, M., & Hoffmann, R. G. (2010) · American Journal of Hematology · doi:10.1002/ajh.21570 · Cited by 382
Self-citationBallas, S. K., & Lusardi, M. (2005) · American Journal of Hematology · doi:10.1002/ajh.20336 · Cited by 286
Use of Health Care Services by Lower-Income and Higher-Income Uninsured Adults
Ross, J. S., Bradley, E. H., & Busch, S. H. (2006) · JAMA · doi:10.1001/jama.295.17.2027 · Cited by 216
Medical care utilization and mortality in sickle cell disease: A population-based study
Shankar, S. M., Arbogast, P. G., Mitchel, E. F., Cooper, W. O., Wang, W. C., & Griffin, M. R. (2005) · American Journal of Hematology · doi:10.1002/ajh.20485 · Cited by 150
Jasti, H., Mortensen, E. M., Obrosky, D. S., Kapoor, W. N., & Fine, M. J. (2008) · Clinical Infectious Diseases · doi:10.1086/526526 · Cited by 149
Panepinto, J. A., Brousseau, D. C., Hillery, C. A., & Scott, J. P. (2004) · Pediatric Blood & Cancer · doi:10.1002/pbc.20180 · Cited by 129
Self-citation
Cited by
Kavanagh, P. L., Fasipe, T. A., & Wun, T. (2022) · JAMA · doi:10.1001/jama.2022.10233 · Cited by 478
Sickle cell pain: a critical reappraisal
Ballas, S. K., Gupta, K., & Adams-Graves, P. (2012) · Blood · doi:10.1182/blood-2012-04-383430 · Cited by 445
Investing in the Health and Well-Being of Young Adults
Stroud, C., Walker, L. R., Davis, M., & Irwin, C. E. (2015) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2014.11.012 · Cited by 435
Mortality Rates and Age at Death from Sickle Cell Disease: U.S., 1979–2005
Lanzkron, S., Carroll, C. P., & Haywood, C. (2013) · Public Health Reports® · doi:10.1177/003335491312800206 · Cited by 414
Zanoni, B. C., & Mayer, K. H. (2014) · AIDS Patient Care and STDs · doi:10.1089/apc.2013.0345 · Cited by 395
Metadata
- Authors
- Brousseau, D. C.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2010-04-07
- Volume
- 303
- Issue
- 13
- Pages
- 1288
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W1981403169
- Cited by
- 637
- References
- 20
- FWCI
- 10.11
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Acute Care Utilization and Rehospitalizations for Sickle Cell Disease. https://app.cochat.ai/papers/10.1001/jama.2010.378
- The paper
- Brousseau, D. C. (2010). Acute Care Utilization and Rehospitalizations for Sickle Cell Disease. JAMA. https://doi.org/10.1001/jama.2010.378
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.